COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
about
HLA antigens and seronegative rheumatoid arthritis.Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritisRheumatism in industry: a review.Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis.The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.Cancer morbidity in rheumatoid arthritis.Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases.Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.Functional capacity and treatment data from a community based study of patients with rheumatoid arthritisMortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.Sulphasalazine and regression of rheumatoid nodulesAustralian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data.Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study.Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritisMicroalbuminuria in patients with rheumatoid arthritisPredictors of disability in a longitudinal sample of patients with rheumatoid arthritis.Serum biochemical values in rheumatoid disease.Bacteriuria in rheumatoid arthritis.Prognosis of rheumatoid arthritis. A prospective survey over 11 years.Follow-up study of 100 cases of juvenile rheumatoid arthritis.A clinical and serological study of rheumatoid arthritisSignificance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study.The links between joint damage and disability in rheumatoid arthritis.Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritisTen year mortality and causes of death in patients with rheumatoid arthritis.Mortality of rheumatoid arthritis in Japan: a longitudinal cohort studyA long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugsThe incidence of allergic disorders and cancer.Bilateral pneumothoraces and pleural effusions in rheumatoid lung disease.The world of biologics.Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s.Assessment of radiological changes in the hands and feet in rheumatoid arthritis. Their correlation with prognosisRenal disease and drug therapy in rheumatoid arthritisEvaluation of digital joint circumference measurements in rheumatoid arthritis.Multi-variate analysis of serum protein rheumatoid arthritis.Current concepts in the treatment of rheumatoid arthritis.Management of rheumatoid arthritis in the community.
P2860
Q24514541-3B7DB55C-7EDB-4EE6-93C8-F8F38D9A9F02Q28189406-89AD322C-42D2-41B8-A433-321B49A45859Q28769963-07EC1F94-A331-4665-B265-7037EC1C3223Q33552918-4ECB7B8B-BA7A-4DE7-999C-2E5C75409BEDQ33554543-82BD2B61-A8ED-4312-8FC6-6E20B93A48CEQ33555193-A1FB8BB1-FD49-406C-ACB0-54F7EA9CF04DQ33555200-4E796095-FCE0-48F4-BE1A-33BF367BAE64Q33555416-D8DBC4D4-6351-4E50-BB9F-B0E68F4BA340Q33555771-7A76231C-489D-4F13-AE2B-345806C7E752Q33556530-C75059E5-2A00-4218-9A64-F7B6D46D57F4Q33556875-3A5F2E0E-DA3F-47EA-B7FC-020823B6933EQ33557331-EA946943-B39C-46EF-8EE9-41072A2AD54CQ33561006-4E56F59D-F1FE-43BC-8889-7004438ECEEAQ33561343-B55A8073-6DD9-4D89-928A-2271510F009BQ33562682-18044E33-7FBA-4186-881E-A8FF72982A24Q33565041-EA59A2CA-5A0E-44A2-ACA0-C9ED964D7B99Q33566104-CE395799-BC36-4EC1-ADE5-A73A950D39D1Q33567099-B109E89A-4F0D-40B0-B06C-3295083FD062Q33567552-BAAD4E94-EE47-485F-B176-5E02815FD8A5Q33567771-86F8D174-E8BE-4BB8-A2F8-D02CD32F4475Q33568520-0ABE78F0-D775-4144-B9DE-A8EEFD15F06EQ33568634-56BF937B-6719-46B4-9B47-0DF78E1CBA6FQ33568777-0F909E95-7444-4F37-8424-BF9698357891Q33579735-7A9DC4D1-7345-4FC1-B5AF-DC53E44FBF12Q33626939-7C068046-2FA4-4220-AAE9-F26F2963A909Q33867923-488EECD6-FDB6-4813-BA4D-17B43BA2C8F2Q34067442-FCF058C9-E86B-4609-BF3B-23799018F616Q34485318-1DE8047D-4352-4432-82DF-5788CD205E76Q35554834-8DF84269-9CA1-471C-B432-ABAB24548E77Q35638528-C270CA63-21EB-4280-824C-77B069E8C616Q36036847-8C015059-9D44-49A6-9182-0899AF5330ACQ36135474-3BA3E2AB-091B-4FDB-B8F6-3A6A6EA1E66DQ36458132-0CA749C9-6026-450E-BCB1-7A70EC1FBC65Q36647506-8084B4D3-D48D-446D-A933-56726C8D420CQ36756054-51E045A3-02A9-40C0-BC9B-53034B7D82ABQ36756202-F667083B-C66F-4795-A292-3F41F96B4CD0Q39326060-4D23AC56-FCA8-4DA1-B93D-CE78D6B33B31Q39389399-232C2A3E-3B23-42B2-8212-22BEFC301230Q39728213-76C88E42-3AC3-48D3-A0CC-608B5663EA4DQ40465791-ACF0729B-2D7F-4629-86A0-311031F8C5BF
P2860
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
description
1964 nî lūn-bûn
@nan
1964 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@ast
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@en
type
label
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@ast
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@en
prefLabel
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@ast
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@en
P2093
P2860
P356
P1476
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.
@en
P2093
P2860
P304
P356
10.1136/ARD.23.3.193
P407
P577
1964-05-01T00:00:00Z